AI

biotech

FDA Orphan Drug Designation and Rare Pediatric Disease Designation for sarcoma drug

Jim Cornall - October 6, 2026

biotech

Confidence boost for AI virtual cells for novel target discovery

Jim Cornall - October 6, 2026

biotech

Anti-fibrotic drug could be repurposed to control cell communication

Jim Cornall - October 6, 2026

biotech

Positive data from oral therapy designed to improve muscle function and body composition

Jim Cornall - October 5, 2026

AI

Disrupt.com to invest $100m into UAE AI startups

Jim Cornall - March 3, 2025

AI

Verint expands Global Innovation Center in India

Jim Cornall - February 21, 2025

AI

AI-driven breakthrough could accelerate bioeconomy

Jim Cornall - February 19, 2025

AI

iPRONICS raises €20m to advance optical networking

Jim Cornall - February 4, 2025

AI

VuNet raises $7m to boost global expansion and product innovation

Jim Cornall - January 29, 2025

AI

Pasqal and EDF address electric vehicle charging with quantum computing

Jim Cornall - January 23, 2025

AI

Perciv AI secures €2.5m to expand radar solutions

Jim Cornall - December 23, 2024

AI

NSAIT and ETH Zurich Entrepreneurs launch LogicStar AI

Jim Cornall - December 16, 2024

1...345...7 Page 4 of 7

Stay Connected

- Advertisement -

spot_img

Latest Articles

biotech

FDA Orphan Drug Designation and Rare Pediatric Disease Designation for sarcoma drug

Jim Cornall - October 6, 2026 0

UTR Therapeutics Inc. has announced that the U.S. Food and Drug Administration (FDA) has granted Orphan Drug Designation (ODD) to 3′UTRMYCN M1-14 (UTRxMYCN M1-14)...

Confidence boost for AI virtual cells for novel target discovery

biotech Jim Cornall - October 6, 2026 0

Anti-fibrotic drug could be repurposed to control cell communication

biotech Jim Cornall - October 6, 2026 0

Positive data from oral therapy designed to improve muscle function and body composition

biotech Jim Cornall - October 5, 2026 0

Pneumonia can reveal undiagnosed blood cancer

biotech Jim Cornall - October 5, 2026 0